Atlas Trials

Protein Intake Dosage on the Prognosis of Neurocritical Patients

Clinical trial NCT07295301 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07295301
Sponsor
Wenshan City People's Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Neurocritical ConditionsTraumatic Brain InjuryIschemic Stroke
Start date
2025-12-01
Primary completion
2028-06-01
Enrollment
216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.